Share This

Related Topics News -

     
 Title only   |   Print 
     
亞盛醫藥-B四項臨床研究入選美國臨床腫瘤學會年會

2024-04-25T  
亞盛醫藥主席均價17.08元增持8萬股

2024-04-09T  
亞盛醫藥-B在美國癌症研究協會年會披露三項研究進展

2024-04-08T  
亞盛醫藥主席及非執董合共認購23萬股

2024-04-04T  
《公司業績》亞盛醫藥-B全年虧損擴大至9.26億元人民幣

2024-03-28T  
亞盛醫藥-B三項臨床前進展將在美國癌症研究協會年會上披露

2024-03-06T  
亞盛醫藥-B獲美國許可開展奧雷巴替尼3期臨床試驗

2024-02-14T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.